Because of VEGF’s potent and diverse effects on endothelial cells [52] and the nervous system, a challenge for current and future research is to clarify the usefulness of this growth factor as a therapeutic agent for ischemic injury and stroke intervention, particularly in regard to its angiogenic and neuroprotective capacities [3,5,23,44,48]. This evidence concerns the gene VEGFA and stroke disorder.